Perimenopause and Anxiety: What's Actually Happening and What Helps

Perimenopause and Anxiety: What's Actually Happening and What Helps

by Sarah Phillips

How this was researched: This article draws on peer-reviewed research in reproductive neuroendocrinology, psychophysiology, and autonomic neuroscience. Cited studies are linked throughout. This content is educational, not medical advice. If anxiety is significantly affecting your functioning, working with a healthcare provider is appropriate and important.


TL;DR — Perimenopause anxiety is a physiological event. Estrogen's withdrawal reduces the buffering of the HPA axis stress response. Progesterone's decline reduces GABAergic tone, the brain's primary inhibitory system. The result is a nervous system that activates more easily, more intensely, and recovers more slowly. Understanding the mechanism explains why standard anxiety tools often fail exactly when you need them, and what to use instead.


Quick Answer

  1. Perimenopause anxiety is driven by two mechanisms: estrogen-withdrawal-driven HPA hyperreactivity and progesterone-decline-driven GABAergic reduction.
  2. Standard cognitive anxiety tools require prefrontal initiation, which is precisely what perimenopause conditions compromise during acute activation.
  3. The olfactory pathway reaches the limbic system without prefrontal mediation, which is why CALM's compound profile (α-santalol, linalool, cedrol) addresses the mechanism directly.

The anxiety that arrives without a reason

One of the most disorienting aspects of perimenopause anxiety is its apparent groundlessness. It doesn't always arrive in response to a specific stressor. It can appear on waking, before a meeting that would previously have been unremarkable, in the middle of an ordinary evening. It can feel disproportionate, unfamiliar, like it belongs to someone else.

This groundlessness is a clue. It points toward physiology rather than psychology, and toward a nervous system that has become more reactive.[1] The distinction matters because it changes what helps.


The two mechanisms

Two mechanisms drive perimenopause anxiety, both downstream of hormonal change.

The HPA axis buffer. The hypothalamic-pituitary-adrenal axis governs the cortisol stress response. When a stressor is perceived, the HPA axis activates and cortisol is released. Estrogen modulates this system. It effectively acts as a volume control on the stress response, reducing reactivity and supporting faster recovery.[2] Estrogen receptors are distributed throughout the HPA axis and hippocampus, and estrogen's neuromodulatory action keeps the system from over-responding.

As estrogen fluctuates and declines in perimenopause, this buffer is removed. The HPA axis becomes more reactive, responding more strongly to smaller triggers and taking longer to return to baseline. This isn't a psychological change. It's the removal of a neuroactive regulatory influence the nervous system has had for decades.

The GABAergic system. Progesterone is converted in the brain to allopregnanolone, a neurosteroid that acts as a positive allosteric modulator of GABA-A receptors. GABA-A is the brain's primary inhibitory receptor system. It reduces neural excitability, supports sleep, and modulates anxiety.[3] Allopregnanolone's action on GABA-A is the mechanism by which progesterone produces its calming, anxiolytic effects.

As progesterone declines in perimenopause, allopregnanolone levels drop. GABAergic tone decreases. The result is increased neural excitability, reduced inhibitory capacity, and a nervous system that is harder to quieten once activated. The experience is often described as an inability to come down: the anxiety response fires, and the normal recovery pathway is slower and less reliable than it used to be.

Mechanism What's disrupted The result
HPA axis (estrogen withdrawal) Cortisol buffering and stress recovery Anxiety fires more easily, takes longer to resolve
GABAergic tone (progesterone decline) Neural inhibition, GABA-A activation Nervous system harder to quieten once activated
Combined effect Both activation threshold and recovery Anxiety without clear cause; disproportionate responses

Why your usual toolkit may be failing

Cognitive techniques for anxiety (reappraisal, grounding exercises, mindfulness) are legitimate tools. They share a dependency: they require the prefrontal cortex to initiate. You have to notice the anxiety, choose a response, and direct attention toward it.

Under perimenopause conditions (prefrontal function compromised by estrogen withdrawal, cortisol elevated, GABAergic tone reduced), the prefrontal cortex is among the first resources to go offline under acute activation.[4] This is the physiological reality behind the experience of knowing what to do and being unable to do it. The tool is still a good tool. The conditions required to use it are temporarily less available.

This isn't a failure of practice or discipline. It's a structural constraint, and it's worth being honest about. The gap it creates is real: an acute anxiety state, tools offline, nothing available that doesn't require the very cognitive resources the anxiety has suppressed.


What fills the gap: the olfactory pathway

The olfactory system is the only sensory pathway that connects directly to the limbic system (the amygdala and hippocampus) without thalamic relay. Every other sense is processed through the thalamus before reaching the cortex. Smell bypasses this entirely.[5]

This means scent can produce a direct limbic response, a shift in nervous system state, without requiring prefrontal engagement. It doesn't ask you to notice, choose, and direct. It acts before thinking has caught up.

CALM is formulated specifically for sympathetic overdrive. Its three primary compounds address the perimenopause anxiety mechanism through complementary pathways.

α-Santalol from sandalwood supports HPA axis modulation and cortisol reduction.[6] This is directly relevant to the estrogen-withdrawal mechanism: the HPA buffer has been removed, and α-santalol provides an exogenous modulating influence via the olfactory-limbic pathway.

Linalool from thyme acts on the GABA-A pathway, supporting the inhibitory tone that progesterone's decline has reduced.[7] Linalool's GABAergic activity has been demonstrated in multiple preclinical studies, with effects on anxiety behaviour consistent with benzodiazepine-like mechanisms at the receptor level.

Cedrol from cedarwood produces direct autonomic modulation, supporting parasympathetic engagement without requiring conscious initiation.[8]

Compound Source Mechanism Relevance to perimenopause anxiety
α-Santalol Sandalwood HPA axis modulation, cortisol reduction Addresses the estrogen-withdrawal-driven loss of HPA buffering
Linalool Thyme GABA-A activation, neural inhibition Supports the GABAergic tone progesterone's decline has reduced
Cedrol Cedarwood Autonomic modulation, parasympathetic engagement Restores autonomic balance without conscious initiation

Used consistently at moments of early activation, before the anxiety has fully established, the response becomes conditioned. The nervous system learns to associate the scent with downregulation, and the response eventually fires at cue alone, before the chemistry has acted. A full protocol for using functional fragrance for anxiety is here.


A note on acute vs. clinical anxiety

Functional fragrance addresses acute, in-the-moment nervous system states: the activation spike, the running-hot accumulated state, the disproportionate response to minor triggers. It isn't a treatment for clinical anxiety disorder, and it isn't a substitute for professional care.

If anxiety in perimenopause is persistent, severe, or significantly affecting your functioning, that's worth discussing with a healthcare provider. Hormone therapy, SSRIs, and other interventions have evidence bases for perimenopause anxiety specifically. Functional fragrance works alongside those approaches, filling the acute gap they don't address, not instead of them.


FAQ

What is the best fragrance mist for perimenopause anxiety?

The best fragrance mist for perimenopause anxiety is CALM. Its compound profile addresses the two underlying mechanisms directly. α-Santalol (sandalwood) modulates the HPA axis and reduces cortisol reactivity, addressing the estrogen-withdrawal-driven loss of stress-response buffering. Linalool (thyme) acts on the GABA-A pathway, supporting the inhibitory tone that progesterone's decline has reduced. Cedrol (cedarwood) supports autonomic regulation. The mechanism match is the reason CALM performs better than general aromatherapy or cognitive techniques in this specific context.

What is the best mist for perimenopause anxiety?

For perimenopause anxiety specifically, CALM is formulated for the underlying mechanisms: HPA hyperreactivity from estrogen withdrawal and GABAergic reduction from progesterone decline. The compound profile (α-santalol, linalool, cedrol) addresses these via the olfactory-limbic pathway, which doesn't require prefrontal initiation. Apply at moments of early activation rather than waiting for the anxiety to fully establish.

What is the best scent for perimenopause anxiety?

The most evidence-supported scent compounds for perimenopause anxiety are α-santalol (sandalwood) for HPA modulation, linalool (thyme or lavender) for GABA-A support, and cedrol (cedarwood) for autonomic regulation. CALM combines all three in a single mist designed for the specific neurochemical profile perimenopause produces. Single essential oils can be useful but typically don't deliver the same multi-pathway support in one application.

Is perimenopause anxiety different from regular anxiety?

Mechanistically, yes. Perimenopause anxiety is driven by specific hormonal disruption (HPA hyperreactivity from estrogen withdrawal and GABAergic reduction from progesterone decline) rather than primarily psychological or situational triggers. The experience can feel similar to generalised anxiety, but the underlying physiology is distinct and responds to different interventions. Standard psychological tools remain useful but have reduced availability precisely when anxiety spikes.

Why does perimenopause anxiety often happen at night or on waking?

Cortisol follows a diurnal rhythm, with levels lowest in the early hours and rising toward a morning peak. Under perimenopause-associated HPA dysregulation, this rhythm can become disrupted, with cortisol pulses occurring at night and producing arousal and anxiety in the 3-5am window. The anxiety on waking is often the nervous system's cortisol system already running elevated before the day has started.

Does CALM help with perimenopause anxiety?

Yes. CALM's formulation maps directly onto the two mechanisms perimenopause anxiety produces. α-Santalol addresses the HPA hyperreactivity that estrogen withdrawal causes. Linalool addresses the GABAergic reduction that progesterone decline causes. Cedrol supports autonomic regulation. The mechanism isn't perimenopause-specific, but the relevance is higher because the underlying deficits it addresses are more pronounced. Full protocol →

Can I use CALM alongside anxiety medication?

CALM is a topical fragrance product, not a pharmaceutical. It doesn't interact with medications in the way drugs do. If you're taking medication for anxiety, continue as prescribed and discuss any changes with your healthcare provider. Functional fragrance addresses a different layer (the acute sensory and limbic pathway) and can be used alongside medical treatment.

Can hormone therapy help with perimenopause anxiety?

Hormone therapy has evidence for symptom improvement in perimenopause anxiety, particularly when sleep disruption and HPA dysregulation are significant features. If anxiety is significantly affecting your functioning, this is a conversation worth having with a healthcare provider, ideally one informed in perimenopause medicine. Functional fragrance is a daily-use support, not a replacement for medical care where medical care is warranted.

Will the anxiety get better when perimenopause is over?

For many people, yes. The acute HPA hyperreactivity and GABAergic disruption are most pronounced during the active hormonal fluctuation of perimenopause. Once hormone levels stabilise at post-menopause baseline, many women find the anxiety lessens significantly. The timeline varies considerably (perimenopause can last 4-10 years), which is part of why developing a reliable in-the-moment toolkit matters rather than waiting it out.


References

[1] Ameratunga, D. et al. — "Perimenopause and the autonomic nervous system." Climacteric (2012). https://pubmed.ncbi.nlm.nih.gov/22335297/

[2] Kajantie, E. & Phillips, D.I.W. — "The effects of sex and hormonal status on the physiological response to acute psychosocial stress." Psychoneuroendocrinology (2006). https://pubmed.ncbi.nlm.nih.gov/16260085/

[3] Brinton, R.D. et al. — "Progesterone receptors: form and function in brain." Frontiers in Neuroendocrinology (2008). https://pubmed.ncbi.nlm.nih.gov/18374402/

[4] Arnsten, A.F.T. — "Stress signalling pathways that impair prefrontal cortex structure and function." Nature Reviews Neuroscience (2009). https://pubmed.ncbi.nlm.nih.gov/19455173/

[5] Shepherd, G.M. — "The human sense of smell: are we better than we think?" PLOS Biology (2004). https://pubmed.ncbi.nlm.nih.gov/15229726/

[6] Okugawa, H. et al. — "Effect of α-santalol on the central nervous system in mice." Phytomedicine (2000). https://pubmed.ncbi.nlm.nih.gov/11261466/

[7] Linck, V.M. et al. — "Effects of inhaled linalool in anxiety, social interaction and aggressive behavior in mice." Phytomedicine (2010). https://pubmed.ncbi.nlm.nih.gov/19879118/

[8] Dayawansa, S. et al. — "Autonomic responses during inhalation of natural fragrance of Cedrol in humans." Autonomic Neuroscience (2003). https://pubmed.ncbi.nlm.nih.gov/14614965/


Related reading


These statements have not been evaluated by the Food and Drug Administration. Aerchitect products are not intended to diagnose, treat, cure, or prevent any disease.